CStone Pharmaceuticals (HKG:2616)
Hong Kong · Delayed Price · Currency is HKD 4.630
+0.070 (1.54%)
Jun 18, 2026, 4:08 PM HKT
CStone Pharmaceuticals Market Cap
CStone Pharmaceuticals has a market cap or net worth of 7.29 billion as of June 18, 2026. Its market cap has increased by 40.22% in one year.
Market Cap
7.29B
Enterprise Value
6.60B
Revenue
299.99M
Ranking
n/a
PE Ratio
n/a
Stock Price
4.63
Market Cap Chart
Since February 26, 2019, CStone Pharmaceuticals's market cap has decreased from 12.65B to 7.29B, a decrease of -42.41%. That is a compound annual growth rate of -7.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 7.29B | -6.18% |
| Dec 31, 2025 | 7.77B | 164.57% |
| Dec 31, 2024 | 2.94B | 1.52% |
| Dec 29, 2023 | 2.89B | -47.58% |
| Dec 30, 2022 | 5.52B | -42.71% |
| Dec 31, 2021 | 9.63B | -16.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 26, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| LongBio Pharma (Suzhou) | 10.39B |
| HBM Holdings | 9.74B |
| Everest Medicines | 9.31B |
| CARsgen Therapeutics Holdings | 9.25B |
| Suzhou Ribo Life Science | 8.53B |
| Shanghai Haohai Biological Technology | 7.22B |
| Alphamab Oncology | 6.92B |
| Lepu Biopharma | 6.68B |